Odyssey Therapeutics (ODTX) Sale and Maturity of Investments (2023 - 2026)
Odyssey Therapeutics' Sale and Maturity of Investments - Total came in at $43.78 million for Q3 2026, up 244.7% from $12.7 million a year earlier and up 25.3% from the prior quarter.
Odyssey Therapeutics (ODTX) Sale and Maturity of Investments (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Odyssey Therapeutics reported Sale and Maturity of Investments - Total of $148.63 million, up 30.1% year-over-year; for FY2025, it came in at $105.9 million, down 29.5% from FY2024.
- Going back by year, Sale and Maturity of Investments - Total was $150.16 million in FY2024 (+92.2%) and $78.12 million in FY2023.
- The Q3 2026 figure represents the highest quarterly Sale and Maturity of Investments - Total in data going back to Q4 2023.
- Year-over-year, Sale and Maturity of Investments - Total increased in three of the last five quarters, with growth averaging 55.6%.
- Business Quant data shows ODTX's Sale and Maturity of Investments - Total at $34.95 million (Q2 2026), $34.95 million (Q1 2026) and $34.95 million (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Odyssey Therapeutics | 929.15 Mn | -64.53 Mn | - | 43.78 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 43.78 Mn |
| Jun 30, 2026 | 34.95 Mn |
| Mar 31, 2026 | 34.95 Mn |
| Dec 31, 2025 | 34.95 Mn |
| Sep 30, 2025 | 12.70 Mn |
| Jun 30, 2025 | 23.25 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Dec 31, 2024 | 43.33 Mn |
| Dec 31, 2023 | 42.21 Mn |
Odyssey Therapeutics Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ODTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "ODTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ODTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();